Hypothesis

3 Matching Annotations

Last 7 days
www.sciencedirect.com www.sciencedirect.com

Perioperative pembrolizumab in locally advanced cutaneous squamous cell carcinoma: A prospective phase 2 clinical trial

1
1. scibot 07 Nov 2026
  
  in Public
  
  RRID:AB_2819943
  
  DOI: 10.1016/j.cpblue.2026.100150
  
  Resource: (BioLegend Cat# 312618 (also 312617), RRID:AB_2819943)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2819943
  
  What is this?
  
  RRID:AB_2819943
Visit annotations in context

Tags

RRID:AB_2819943

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S3051383926001489
Sep 2024
www.sciencedirect.com www.sciencedirect.com

Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy

1
1. scibot 04 Sep 2024
  
  in Public
  
  AB_2819943
  
  DOI: 10.1016/j.crmeth.2024.100843
  
  Resource: (BioLegend Cat# 312618 (also 312617), RRID:AB_2819943)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2819943
  
  What is this?
  
  RRID:AB_2819943
Visit annotations in context

Tags

RRID:AB_2819943

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2667237524002169
Nov 2023
www.sciencedirect.com www.sciencedirect.com

TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma

1
1. scibot 29 Nov 2023
  
  in Public
  
  RRID:AB_2819943
  
  DOI: 10.1016/j.isci.2023.108353
  
  Resource: (BioLegend Cat# 312618 (also 312617), RRID:AB_2819943)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2819943
  
  What is this?
  
  RRID:AB_2819943
Visit annotations in context

Tags

RRID:AB_2819943

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2589004223024306